Since 2005, ten face transplants have been performed in four countries: France, the USA, China, and Spain. These encouraging short-term outcomes, with the longest survivor approaching 5 years, have led to an increased interest in establishing face transplant programs worldwide. Therefore, the purpose of this chapter is to facilitate the dissemination of relevant details as per our experience in an effort to assist those medical centers interested in obtaining an Institutional Review Board (IRB)-approved protocol. In this chapter, we address the logistical challenges involved with face transplantation including: essential program requirements, pertinent protocol details, face transplant team assembly, project funding, the organ procurement organization (OPO), and the coroner. It must be emphasized that face transplantation is still experimental and its therapeutic value remains to be validated. All surgical teams pursuing this endeavor must dedicate an attention to detail and should accept a responsibility to publish their outcomes in a transparent manner in order to contribute to the international field. However, due to its inherent complexity, facial transplantation should only be performed by university-affiliated medical institutions capable of orchestrating a specialized multidisciplinary team with a long-term commitment to its success.
Team Leader Transplant Surgeon Organ Procurement Organization Face Transplant Institutional Review Board Protocol
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357:2451.PubMedCrossRefGoogle Scholar
Gordon CR, Siemionow M, Papay F, et al. The world’s experience with facial transplantation: what have we learned thus far? Ann Plast Surg. 2009;63:121-127.CrossRefGoogle Scholar
Guo S, Han Y, Zhang X, Lu B, et al. Human facial allotransplantation: a 2-year follow-up study. Lancet. 2008;372:631-638.PubMedCrossRefGoogle Scholar
Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet. 2008;372:639-645.PubMedCrossRefGoogle Scholar
Siemionow M, Zor F, Gordon CR. Face, upper extremity, and concomitant transplantation: future challenges and potential concerns. Plast Reconstr Surg. 2010;126(1):308-315.PubMedCrossRefGoogle Scholar
American Society of Reconstructive Transplantation. Website home page. http://www.a-s-r-t.com. Accessed November 29, 2009.
Siemionow M, Papay F, Alam D, et al. First U.S. near-total human face transplantation – a paradigm shift for massive facial injuries. Lancet. 2009;374:203-209.PubMedCrossRefGoogle Scholar
Siemionow M, Papay F, Djohan R, et al. First U.S. near-total human face transplantation – a paradigm shift for massive facial injuries. Plast Reconstr Surg. 2010;125(1):111-122.PubMedCrossRefGoogle Scholar
Gordon CR, Nazzal J, Lozano-Calderan SA, et al. From experimental rat hindlimb to clinical face composite tissue allotransplantation: historical background and current status. Microsurgery. 2006;26:566-572.PubMedCrossRefGoogle Scholar
Siemionow M, Demir Y, Mukherjee A, Klimczak A. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants. Transplantation. 2005;79:558-567.PubMedCrossRefGoogle Scholar
Demir Y, Ozmen S, Klimczak A, Mukherjee AL, Siemionow M. Tolerance induction in composite facial allograft transplantation in the rat model. Plast Reconstr Surg. 2004;114:1790-1801.PubMedCrossRefGoogle Scholar
Siemionow M, Gozel-Ulusal B, Engin Ulusal A, Ozmen S, Izycki D, Zins JE. Functional tolerance following face transplantation in the rat. Transplantation. 2003;75:1607-1609.PubMedCrossRefGoogle Scholar
Siemionow M, Ortak T, Izycki D, et al. Induction of tolerance in composite tissue allografts. Transplantation. 2002;74:1211-1217.PubMedCrossRefGoogle Scholar
Gozel-Ulusal B, Ulusal AE, Ozmen S, Zins JE, Siemionow MZ. A new composite facial and scalp transplantation model in rats. Plast Reconstr Surg. 2003;112:1302-1311.CrossRefGoogle Scholar
Gordon CR, Siemionow M, Coffman K, et al. The Cleveland clinic FACES score: a preliminary assessment tool for identifying the optimal face transplant candidate. J Craniofac Surg. 2009;20(6):1969-1974.PubMedCrossRefGoogle Scholar
Morris P, Bradley A, Doyal L, et al. Face transplantation: a review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation. 2007;83:109-128.PubMedCrossRefGoogle Scholar
Gordon CR, Siemionow M. Requirements for establishing a hand transplant program. Ann Plast Surg. 2009;63:262-273.PubMedCrossRefGoogle Scholar
Siemionow M, Unal S, Agaoglu G, Sari A. A cadaver study in preparation for facial allograft transplantation in humans: part I. What are alternative sources for total facial defect coverage? Plast Reconstr Surg. 2006;117:864-872.PubMedCrossRefGoogle Scholar
Siemionow M, Agaoglu G, Unal S. A cadaver study in preparation for facial allograft transplantation in humans: part II. Mock facial transplantation. Plast Reconstr Surg. 2006;117:876-885.PubMedCrossRefGoogle Scholar
Siemionow M, Papay F, Kulahci Y, et al. Coronal-posterior approach for face/scalp flap harvesting in preparation for face transplantation. J Reconstr Microsurg. 2006;22:399-405.PubMedCrossRefGoogle Scholar
Siemionow M, Agaoglu G. The issue of “facial appearance and identity transfer” after mock transplantation: a cadaver study in preparation for facial allograft transplantation in humans. J Reconstr Microsurg. 2006;22:329-334.PubMedCrossRefGoogle Scholar
Agich GJ, Siemionow M. Until they have faces: the ethics of facial allograft transplantation. J Med Ethics. 2005;12:707-709.CrossRefGoogle Scholar
Brill SE, Clarke A, Veale DM, Butler PE. Psychological management and body image issues in facial transplantation. Body Image. 2006;3:1-15.PubMedCrossRefGoogle Scholar
Glazier AK. Regulatory face-off: what agency should oversee face transplants? Am J Transplant. 2008;8:1393-1395.PubMedCrossRefGoogle Scholar
Clarke A, Malloy J, White P, et al. A model for structuring the donor discussion in emergent transplant procedures. Prog Transplant. 2008;18:157-161.PubMedGoogle Scholar